Cutaquig 165 mg/mL
immunoglobulin G · SOLUTION · Pfizer Laboratories Div Pfizer Inc
No Recall History
Plain English
Cutaquig is a solution containing immunoglobulin g at 165 mg/mL, taken subcutaneous. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Cutaquig
- Generic Name
- immunoglobulin G
- NDC Code (Product)
0069-1802- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 165 mg/mL
- Dosage Form
- SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125668
- Marketing Start
- 09/13/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Cutaquig used for?
Cutaquig contains immunoglobulin G. It is a solution taken subcutaneous. Consult your doctor for specific uses.
Is Cutaquig a controlled substance?
Cutaquig is not classified as a controlled substance by the DEA.
What is the generic name for Cutaquig?
The generic name for Cutaquig is immunoglobulin G. There are no other listed brand versions of immunoglobulin G.
What is the NDC code for Cutaquig 165 mg/mL?
The NDC (National Drug Code) for Cutaquig 165 mg/mL is 0069-1802, listed by Pfizer Laboratories Div Pfizer Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)